Filing Details
- Accession Number:
- 0000950170-24-128956
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 19:59:14
- Reporting Period:
- 2024-11-19
- Accepted Time:
- 2024-11-19 19:59:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808865 | Iteos Therapeutics Inc. | ITOS | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816194 | Matthew Gall | C/O Iteos Therapeutics, Inc. 321 Arsenal Street Watertown MA 02472 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-19 | 5,000 | $7.73 | 65,429 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
